Quidel : Quidel to Hold 2007 First Quarter Financial Results Conference Call on April 26
04/19/2007| 07:00am US/Eastern
Quidel Corporation (Nasdaq:QDEL), a leading provider of rapid
point-of-care diagnostic tests, will release 2007 first quarter
financial results after market close on Thursday, April 26, 2007.
Following the release of the results, Caren L. Mason, president and
chief executive officer, and John M. Radak, chief financial officer,
will host an investment community conference call beginning at 5:00 p.m.
ET (2:00 p.m. PT) to discuss those results and to answer questions.
To participate in the live call by telephone from the U.S., dial (888)
803-7396, or from outside the U.S. dial (706) 634-1052. A live webcast
of the call can be accessed at www.quidel.com.
The web site replay will be available for 14 days and the telephone
replay will be available for 48 hours by dialing (800) 642-1687 from the
U.S., or (706) 645-9291 for international callers, and entering
reservation number 5521515.
Quidel Corporation serves to enhance the health and well being of people
around the globe through the discovery, development, manufacturing and
marketing of rapid diagnostic solutions at the point of care (POC) in
infectious diseases and reproductive health. Marketed under the leading
brand name of QuickVue®,
Quidel's portfolio of products currently
includes tests that aid in the diagnosis of several disease or condition
states, including influenza, respiratory syncytial virus, Fecal Occult
Blood, Strep A, pregnancy, bacterial vaginosis, infectious
mononucleosis, H. pylori and Chlamydia. Quidel's products are
sold to healthcare professionals with a focus on the physician office
lab and acute care markets through leading medical distribution partners
on a worldwide basis. Quidel's Specialty Products Group (SPG) develops
research products in the fields of oncology and bone health with
potential future point-of-care applications. By building value in rapid
diagnostic tests, Quidel provides leadership to the industry and among
healthcare professionals allowing for the movement of patient testing
out of the central laboratory setting and into the physician office,
urgent care and other outpatient settings where rapid testing and
treatment has an impact on clinical outcomes and provides an economic
benefit. For more information, visit www.quidel.com,
www.flutest.com, or www.colorectal-test.com.
© Business Wire 2007